Thermo Fisher Scientific will be at CPHI Barcelona, October 24-26. Find us at booth #3K50 or schedule a meeting today.
Pharmaceutical companies walk a tightrope in early drug development. They have to balance speed, quality, scientific risk, and API cost. Compromising on any one of these four crucial elements can prove fatal to a product candidate. Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development.
Author: Anil Kane, Ph.D., MBA